Status: Not yet recruiting
Tafenoquine Combinations for Improved Radical Cure Efficacy of Plasmodium Vivax
This study is to conduct a clinical trial of tafenoquine combinations to compare the rates of therapeutic efficacy of dihydroartemisinin-piperaquine or artemether-lumefantrine with tafenoquine to chloroquine plus tafenoquine in preventing recurrence of Plasmodium vivax over a 6-month period in adult subjects with uncomplicated P. vivax infection living in Thailand.
Participants needed: 300
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Walter Reed Army Institute of Research (WRAIR)Updated: Apr 16, 2026Locations: 1
Eligibility criteria
Thai or non-Thai, male or non-pregnant/non-lactating female, aged at least 18 ye... [+4]
Have an allergic reaction to any of the study drugs or components (AL,TQ, artemi... [+11]